Rashid Shirya, Sniderman Allan, Melone Michelle, Brown Patrick E, Otvos James D, Mente Andrew, Schulze Karleen, McQueen Matthew J, Anand Sonia S, Yusuf Salim
Department of Pharmacology, Dalhousie University, Saint John and Halifax, Canada
Department of Medicine, McGill University, Montreal, Canada.
Eur J Prev Cardiol. 2015 Apr;22(4):468-77. doi: 10.1177/2047487314528461. Epub 2014 Mar 21.
Why South Asians are at increased risk of premature atherosclerotic cardiovascular diseases compared with other ethnic groups is not fully understood. Atherogenic dyslipoproteinemia - hypertriglyceridemia, elevated numbers of low-density lipoprotein (LDL) particles and low high-density lipoprotein cholesterol (HDL-C) - is more common in South Asians but the mechanisms responsible have not been explicated. Here we examined whether the circulating lipid transfer protein, cholesteryl ester transfer protein (CETP), plays a role in the pathogenesis of the atherogenic dyslipoproteinemia among South Asians.
CETP activity was determined by exogenous substrate assay in the serum of healthy, metabolically well-characterized individuals of South Asian and European descent (N = 244 and 238, respectively). Serum and lipoprotein lipids and apolipoproteins were measured and lipoprotein particle number and size were quantified via nuclear magnetic resonance spectroscopy. All the elements of the atherogenic dyslipoproteinemia were more severe in South Asians and CETP activity was significantly greater by 30% in South Asians compared with Europeans, adjusted for age, sex, body mass index and waist circumference (p < 0.0001). CETP activity was directly associated with serum triglycerides and inversely with HDL-C in the whole population. CETP activity was also directly related to apoB and LDL particle number. Finally, increased CETP activity was associated with pro-atherogenic reductions in HDL and LDL particle size.
We identified novel associations between elevated CETP activity and the triad of quantitative and qualitative lipoprotein abnormalities in the atherogenic dyslipidemia in South Asians, a major contributor of increased atherosclerotic cardiovascular diseases in South Asians.
与其他种族群体相比,南亚人过早发生动脉粥样硬化性心血管疾病的风险增加,其原因尚未完全明确。致动脉粥样硬化性血脂异常——高甘油三酯血症、低密度脂蛋白(LDL)颗粒数量增加和高密度脂蛋白胆固醇(HDL-C)降低——在南亚人中更为常见,但其潜在机制尚未阐明。在此,我们研究了循环脂质转运蛋白胆固醇酯转运蛋白(CETP)是否在南亚人致动脉粥样硬化性血脂异常的发病机制中起作用。
通过外源底物测定法,在健康、代谢特征明确的南亚裔和欧洲裔个体(分别为N = 244和238)的血清中测定CETP活性。测量血清和脂蛋白脂质及载脂蛋白,并通过核磁共振波谱法定量脂蛋白颗粒数量和大小。在调整年龄、性别、体重指数和腰围后,南亚人致动脉粥样硬化性血脂异常的所有要素都更为严重,且南亚人的CETP活性比欧洲人显著高30%(p < 0.0001)。在整个人群中,CETP活性与血清甘油三酯直接相关,与HDL-C呈负相关。CETP活性也与载脂蛋白B和LDL颗粒数量直接相关。最后,CETP活性增加与HDL和LDL颗粒大小的促动脉粥样硬化性降低有关。
我们发现,CETP活性升高与南亚人致动脉粥样硬化性血脂异常中脂蛋白定量和定性异常三联征之间存在新的关联,南亚人动脉粥样硬化性心血管疾病增加的一个主要因素。